NEXENTIS TECHNOLOGIES INC. Fair Value of Long-Term Debt
NEXENTIS TECHNOLOGIES INC. (NXTS) had Fair Value of Long-Term Debt of $505.77 thousand as of 2021-03-31, per its 10-Q filed 2021-05-18.
Discontinued › Notes › Debt Instruments
us-gaap:LongTermDebtFairValue · last filed 2022-03-31
- 2021-03-31: Long-term Debt, Fair Value $505.77K.
- 2020-12-31: Long-term Debt, Fair Value $54.97K.
- 2020-09-30: Long-term Debt, Fair Value $18.69K.
| Period end | Long-term Debt, Fair Value |
|---|---|
| 2021-03-31 | $505.77K 10-Q · filed 2021-05-18 |
| 2020-12-31 | $54.97K 10-K · filed 2022-03-31 |
| 2020-09-30 | $18.69K 10-Q · filed 2020-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |